Skip to main content

    Role of AI in Retina


    AAO Artificial Intelligence Committee member Dr. Judy Kim discusses how the image-driven field of retina is poised to use artificial intelligence. From AI-driven screening devices for diabetic retinopathy to predicting how a disease will progress, she touches on several ways in which AI is already being used in retina as well as on future directions.

    Financial Disclosures: Dr. Judy Kim discloses financial relationships with Allergan, Apellis Pharmaceuticals, Bausch + Lomb, Clearside Biomedical, Dutch Ophthalmic Research Center International, Genentech, Novartis, Outlook Therapeutics, Regeneron Pharmaceuticals (Consultant/Advisor); Notal Vision (Grant Support).